Milk Intolerance, Beta-Casein and Lactose
Pal S, Woodford K, Kukuljan S, Ho S, Nutrients. (2015). 7(9), 7285-97. External link
Beta casein A1 and A2 in milk and human health. Report to New Zealand Food Safety Authority
Swinburn B, (2004). Prepared for New Zealand Food Safety Authority, July, 2004. External link
Scientific Report of EFSA prepared by a DATEX Working Group on the potential health impact of ß-casomorphins and related peptides
EFSA Scientific Report (2009). 231, 1-107. External link
The A2 milk case: a critical review
Truswell A.S, (2005). Eur J Cln Nutr. 59(5), 623-31. External link
A critique of Truswell’s A2 milk review
Woodford K.B, (2006). Eur J Clin Nutr. 60(3), 437-9. External link
Further research for consideration in ‘the A2 milk case’
Allison A.J, Clarke A.J, (2006). EurJ Clin Nutr. 60(7), 921-4. External link
Formation and Degradation of Beta-casomorphins in Dairy Processing
Nguyen D.D, Johnson S.K, Busetti F, Solah V.A, Crit Rev Food Sci Nutr. (2015). 55(14), 1955-67. External link
Polymorphism of bovine beta-casein and its potential effect on human health
Kaminski S, Cieslinska A, Kostroyra E, (2007). J Appl Genet. 48(3), 189-98. External link
Health implications of milk containing beta-casein with the A2 genetic variant
Bell S.J, Grochoski G.T, Clarke A.J, (2006). Crit RevFood Sci Nutr. 46(1), 93-100. External link
Caseins as source of bioactive peptides
Silva S.V, Malcata F.X, (2005). International Dairy Journal (15): 1-15. External link
Functional Significance of Bioactive Peptides Derived from Milk Proteins
Kamauab S.M, Lua R, Chena W, Liua X, Tiana F, Shena Y, et al. (2010). Food Reviews International 26(4): 386-401. External link
Opioid peptides encrypted in intact milk protein sequences.
Meisel H & FitzGerald R.J, (2000). Br J Nutr. 84 Suppl 1, S27-31. External link
Opioid activities of beta-casomorphins
Brantl V, Teschemacher H, Blasig J, Henschen A, Lottspeich F, (1981). Life Sci. 28(17),1903-9. External link
Effects of milk-derived bioactives: an overview
Shah N.P, (2000). Br J Nutr. 84 Suppl 1:S3-10. External link
Immunoregulatory peptides in bovine milk
Gill H.S, Doull F, Rutherfurd K.J, Cross M.L, (2000). Br J Nutr. 84(Suppl 1), S111-7. External link
Heart Disease, Diabetes, Gut Immune Suppression and Epidemiology Studies
McLachlan C.N.S & Clarke A.J, (2002). Journal of Nutritional & Environmental Medicine, 12(3), 197-206. External link
Casein, a prohormone with an immunomodulating role for the newborn?
Migliore-Samour D & Jolles P, (1988). Experientia. 44(3), 188-93. External link
Casein-derived bioactive peptides: Biological effects, industrial uses, safety aspects and regulatory status.
Phelan M, Aherne A, FitzGerald R.J, O’Brien N.M, (2009). International Dairy Journal. 19, 643-54. External link
Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing
Gobbetti M, Stepaniak L, De Angelis M, Corsetti A, Di Cagno R, (2002). Crit Rev Food Sci Nutr. 42(3):223-39. External link
Beta-casein in cow’s milk: a major antigenic determinant for type 1 diabetes?
Pozzilli P, (1999). J Endocrinol Invest. 22(7), 562-7. External link
Milk A1 and A2 peptides and diabetes
Clemens R.A, (2011). Nestle Nutr Workshop Ser Pediatr Program. 67:187-95. External link
Intestinal assimilation of intact peptides and proteins from the diet–a neglected field?
Gardner M.L, (1984). Biol Rev Camb Philos Soc. 59(3):289-331. External link
Behavioral effects of food-derived opioid-like peptides in rodents: Implications for schizophrenia?
Lister J, Fletcher PJ, Nobrega JN, Remington G. Pharmacology, biochemistry, and behavior. (2015). 134:70-8. External link
Gluten- and casein-free diets for autistic spectrum disorder (Review)
Millward C, Ferriter M, Calver S, Connell-Jones G, (2008). Cochrane Database Syst Rev. 16;(2):CD003498. External link
Reports on dietary intervention in autistic disorders
Knivsber A.M, Reichelt K.L, Nødland M, (2001). Nutritional neuroscience. 4(1):25-37. External link
Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention
Shattock P, Whiteley P, (2002). Expert Opin Ther Targets. 2002;6(2):175-83. External link
Can the pathophysiology of autism be explained by the nature of the discovered urine peptides?
Reichelt K.L, Knivsberg A.M, (2003). Nutritional neuroscience. 6(1):19-28. External link
Opioid peptides and dipeptidyl peptidase in autism
Shattock P, Hooper M, Waring R, (2004). Dev Med Child Neurol. 46(5):357. External link
Gluten-Free and Casein-Free Diets in the Treatment of Autism Spectrum Disorders: A Systematic Review
Mulloy A, Lang R, O’Reilly M, Sigafoos J, Lancioni G, Rispoli M, (2010). Research in Autism Spectrum Disorders. 4(3):328-39. External link
Minireview. Peptides and the blood-brain barrier
Meisenberg G, Simmons W.H, (1983). Life Sci. 32(23):2611-23. External link
Saturable transport of peptides across the blood-brain barrier.
Banks, W. A & Kastin A. J, (1987). Life Sci. 41(11): 1319-38. External link
Effects of peptides on animal and human behavior: a review of studies published in the first twenty years of the journal Peptides
McLay R.N, Pan W, Kastin A.J, (2001). Peptides. 22(12):2181-255. External link
The role of respiratory failure caused by congenital central nervous system abnormalities and the effect of beta-casomorphins in sudden infant death syndrome pathogenesis
Suminska-Ziemann B, Gos T, Jankowski Z, (2015). Arch Med Sąd Kryminol. 65(2), 99-111. External link
Sudden infant death syndrome and opioid peptides from milk.
Ramabadran K & Moore B.E, (1988). Am J Dis Child. 142(1):12-3. External link
Opioid peptides from milk as a possible cause of sudden infant death syndrome
Ramabadran K & Bansinath M, (1988). Med Hypotheses. 27(3):181-7. External link
Relation of beta-casomorphin to apnea in sudden infant death syndrome
Sun Z, Zhang Z, Wang X, Cade R, Elmir Z, Fregly M, (2003). Peptides. 24(6), 937-43. External link
Does milk increase mucus production?
Bartley J & McGlashan S.R, (2010). Med Hypotheses. 74(4):732-4. External link
Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV
Lambeir A.M, Durinx C, Scharpe S, De Meester I, (2003). Crit Rev Clin Lab Sci. 40(3):209-94. External link
Dipeptidyl-peptidase IV (CD26)–role in the inactivation of regulatory peptides
Mentlein R, (1999). Regul Pept. 85(1):9-24. External link
The material contained within this website’s Health Professionals’ pages is intended solely for presentation to Health Care Professionals (HCPs). The purpose of the materials contained within these pages is threefold:
1) to highlight the extensive body of literature in the A1 beta-casein and beta-casomorphin related areas;
2) to review some of the relevant literature; and
3) to stimulate interest amongst HCPs to obtain and review some of the relevant literature directly.
Liability and Warranties
The a2 Milk Company™ has made reasonable efforts to ensure that the content and the representation of the scientific literature in the Health Professionals’ pages are accurate and not misleading. By presenting the scientific literature as reviews and/or as hyperlinks to scientific publications, The a2 Milk Company™ does NOT make any representation as to the health benefits of A2 dairy foods compared with non-A2 dairy foods. The website is provided ’on face value’ and The a2 Milk Company™ disclaims any and all liability for any third party’s personal interpretation of the scientific information and hyperlinks to any scientific publications in the Health Professionals’ pages. Material in this website should NOT be construed as endorsing any health claim for A2 dairy products, as professional advice or as professional recommendation. The a2 Milk Company™ holds the view that dairy foods are rich in essential nutrients for human health and that dairy foods should form part of a well-balanced diet, as embodied in The NHMRC Australian Dietary Guidelines (2013). The a2 Milk Company™, to the maximum extent permissible at law, expressly excludes all representations and warranties relating to the content and use of this website. The a2 Milk Company™ will not be liable for any loss, liability or damage which you may incur or suffer from your use of these Health Professionals’ pages.
Website Use – License